U.S.-JAPAN COOPERATIVE MEDICAL SCIENCES PROGRAM COLLABORATIVE AWARDS -CRDF GLOBAL

CRDF Global is accepting proposals from joint U.S., Japan, and other regional Asia-Pacific (APac) based investigators working in the field of infectious disease and immunology research for the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) Collaborative Awards, 2019. This initiative is jointly funded by CRDF Global utilizing funds provided by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and the Japan Agency for Medical Research and Development (AMED). USJCMSP Collaborative Awards, 2019 is the third round of a collaborative award program that was initiated in 2016 following the 50th anniversary celebration of the USJCMSP. The awards program aims to promote the inclusion of early-stage and female scientists in collaborative research.

Proposal Deadline: Saturday, December 15, 2018

ELIGIBILITY

Individuals who served as PIs on the 2016 or 2018 USJCMSP collaborative awards cannot apply as PIs in this competition.

All proposals must meet each of the following eligibility criteria:

1) Each proposal must include one PI from each sub-team (U.S., Japan and/or APac team) who will serve together as Co-PIs of the collaborative team. Co-PIs will share overall responsibility for the project and coordinating all project participants and institutions. The institution at which each PI is employed will serve as the individual team’s Principal Institution[1] designated on the proposal. Additional Investigators and institutions may be included as secondary collaborators to each individual team at the discretion of the co-PIs.

2) Each PI must:

• Possess the degree of Ph.D., M.D., or the equivalent research experience 
• Demonstrate scientific capacity and research experience. 
• Be employed at an institution that can serve as the Principal Institution on the award. 

3) On each application it is strongly encouraged that both of the Japanese sub-team and the U.S. sub-team include as a PI an early-stage or female investigator. At least either of the Japanese sub-team or the U.S. sub-team must include an early-stage or female investigator as a PI. In applications that include a collaborating APac sub-team, the APac sub-team must include at least ONE early-stage or female investigator, preferably as the APac sub-team PI. If senior investigators (i.e., non-early-stage) are included as members of the proposed Japanese, U.S. or APac sub-teams, at least one senior investigator involved in each project must be identified as a mentor and trainer who will work with the early-stage investigator(s) involved in each project.

4) Sub-team budget allocation percentages must total 100% for the collaborative team and may not exceed $60,000 USD.

Investigators from the United States, Japan, and other APac countries are invited to jointly apply for funding for collaborative research projects focused on the areas of research listed below and other related topics. Basic and clinical immunology and endemic and emerging infectious diseases relevant to the APac region eligible for this competition are the following:

• Acute Respiratory Infections
• Cholera and other Bacterial Enteric Diseases
• Hepatitis
• Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)
• Immunology related to Infections Diseases
• Nutrition and Metabolism (related to Infectious Diseases and/or Immunology)
• Parasitic Diseases
• Resistance against Anti-Microbial/Viral Agents
• Tuberculosis, Leprosy, and other Mycobacteria
• Other Viral Diseases
• Other Emerging and Reemerging Diseases

More information here: http://www.crdfglobal.org/funding-opportunities/2019-USJCMSP